1DaySooner's Trump II Health Policy Proposals
Read the original on Astral Codex Ten →
Summary
Co-written with Josh Morrison (1DaySooner): an 'upside-only' wishlist of health-policy ideas the new Trump-II HHS/FDA/NIH appointees (Jim O'Neill, Marty Makary, Jay Bhattacharya) might adopt - kidney-donor compensation / End Kidney Deaths Act, longevity biomarkers, an air-quality Operation Warp Speed, FDA transparency (CRLs, Sentinel), regulatory reciprocity, human challenge trials, freeing ARPA-H from NIH. Concrete and well-briefed, but it's curated advocacy: a list of recurring ACX/EA causes pitched at named officials, not a unified argument.
Why this score
Quality 60 · Strong. Solid/Strong edge. Competent, concrete, genuinely informative on real policy levers, and each proposal is explained with its evidence (above a stub) - but it's an advocacy listicle ('upside only' by design) recombining existing 1DaySooner/Tabarrok/Mercatus proposals, with limited original insight or lasting craft, so it sits at the Solid/Strong boundary.
Claude’s paradigm shift 42 · Moderate. Moderate - almost everything here (organ compensation, reciprocity, challenge trials, ARPA-H independence) is a pre-existing proposal; novelty is in the packaging/targeting to specific 2025 appointees, not in the ideas.
Real-world impact 2 · Minor. Direct policy-advocacy intent (aimed at sitting officials, tied to a real bill - the Malliotakis kidney credit), but as a blog post its own material impact is within-discourse; no demonstrated policy movement attributable to it.